PLRZ

Healthcare Biotechnology

Polyrizon Ltd.

$9.61

-0.90 -8.52% today

Price History

Not enough data

Key Stats

Market Cap

23.34M

Avg Volume

62,978

EPS

-$4.96

52W High

$18.20

52W Low

$2.88

Div. Yield

0.0%

Valuation

P/B Ratio

0.84

EV/EBITDA

-0.56

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(21.4%)

Return on Assets

(23.2%)

Liquidity & Leverage

Current Ratio

36.37

Quick Ratio

35.88

Total Cash

16.07M

Total Debt

About

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.